본문 바로가기
KERD
논문KCI 등재

Therapeutic outcomes of methotrexate injection in unruptured interstitial pregnancy

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류산부인과학

초록

Objective: To examine the therapeutic outcomes of methotrexate (MTX) in the treatment of unruptured interstitial pregnancy. Methods: We reviewed the medical records of patients who were diagnosed with interstitial pregnancy and received MTX as first-line treatment between January 2003 and July 2014 at CHA Gangnam Medical Center. The treatment success rates and subsequent pregnancy outcomes were examined. Results: Ninety-seven patients were diagnosed with interstitial pregnancy between January 2003 and July 2014. Of them, 38 initially received MTX treatment. The diagnosis was made at a median of 6+3 weeks (5+0 to 11+3 weeks). Thirty patients received a systemic MTX injection, while the other 8 received a local MTX injection. Systemic treatment composed of an 8-day alternating MTX regimen, single-dose regimen, or high-dose regimen (100 mg/m2 + 200 mg/m2 intravenously over 12 hours). The local injection consisted of a direct MTX injection into the gestational sac with or without systemic MTX injection. Twenty-one patients (55.3%) were successfully treated with MTX. However, MTX therapy failed in 17 patients (44.7%), who required surgery. Mode of MTX treatment was the only predictive variable of MTX treatment success (P=0.039). Treatment success was seen in 7 of 8 patients (87.5%) in the local MTX group vs. 14 of 30 patients (46.7%) in the systemic MTX group. After treatment, 13 patients attempted a successive pregnancy; of them, 10 patients had a confirmed clinical pregnancy and healthy live birth. Conclusion: Combined MTX treatment including a local injection might be an initial approach to the treatment of interstitial pregnancy.

Abstract

Objective: To examine the therapeutic outcomes of methotrexate (MTX) in the treatment of unruptured interstitial pregnancy. Methods: We reviewed the medical records of patients who were diagnosed with interstitial pregnancy and received MTX as first-line treatment between January 2003 and July 2014 at CHA Gangnam Medical Center. The treatment success rates and subsequent pregnancy outcomes were examined. Results: Ninety-seven patients were diagnosed with interstitial pregnancy between January 2003 and July 2014. Of them, 38 initially received MTX treatment. The diagnosis was made at a median of 6+3 weeks (5+0 to 11+3 weeks). Thirty patients received a systemic MTX injection, while the other 8 received a local MTX injection. Systemic treatment composed of an 8-day alternating MTX regimen, single-dose regimen, or high-dose regimen (100 mg/m2 + 200 mg/m2 intravenously over 12 hours). The local injection consisted of a direct MTX injection into the gestational sac with or without systemic MTX injection. Twenty-one patients (55.3%) were successfully treated with MTX. However, MTX therapy failed in 17 patients (44.7%), who required surgery. Mode of MTX treatment was the only predictive variable of MTX treatment success (P=0.039). Treatment success was seen in 7 of 8 patients (87.5%) in the local MTX group vs. 14 of 30 patients (46.7%) in the systemic MTX group. After treatment, 13 patients attempted a successive pregnancy; of them, 10 patients had a confirmed clinical pregnancy and healthy live birth. Conclusion: Combined MTX treatment including a local injection might be an initial approach to the treatment of interstitial pregnancy.

참고문헌 (18)

  1. Faraj R, "Management of cornual (interstitial)pregnancy", Obstet Gynaecol, 9, pp.249~255 (2007)
  2. Surbone A, "Interstitial pregnancies’ diagnosis and management:an eleven cases series", Swiss Med Wkly, 143, pp.w13736~ (2013)
  3. Marion LL, "Ectopic pregnancy: history, incidence, epidemiology, and risk factors", Clin Obstet Gynecol, 55, pp.376~386 (2012)
  4. Lau S, "Conservative medical and surgical management of interstitial ectopic pregnancy", Fertil Steril, 72, pp.207~215 (1999)
  5. Takeda A, "Successful management of interstitial pregnancy with fetal cardiac activity by laparoscopicassisted cornual resection with preoperative transcatheter uterine artery embolization", Arch Gynecol Obstet, 280, pp.305~308 (2009)
  6. Tulandi T, "Interstitial pregnancy: results generated from the Society of Reproductive Surgeons Registry", Obstet Gynecol, 103, pp.47~50 (2004)
  7. Sagiv R, "Interstitial pregnancy management and subsequent pregnancy outcome", Acta Obstet Gynecol Scand, 92, pp.1327~1330 (2013)
  8. Hajenius PJ, "Serum human chorionic gonadotropin clearance curves in patients with interstitial pregnancy treated with systemic methotrexate", Fertil Steril, 66, pp.723~728 (1996)
  9. Borgatta L, "Single dose methotrexate therapy: application to interstitial ectopic pregnancy", Int J Gynaecol Obstet, 60, pp.279~282 (1998)
  10. Talmon R, "Successful treatment of cornual pregnancy with 1-day high-dose methotrexate regimen and folinic acid rescue", Gynecol Obstet Invest, 35, pp.243~244 (1993)
  11. Benifla JL, "Alternative to surgery of treatment of unruptured interstitial pregnancy: 15 cases of medical treatment", Eur J Obstet Gynecol Reprod Biol, 70, pp.151~156 (1996)
  12. Tanaka T, "Treatment of interstitial ectopic pregnancy with methotrexate: report of a successful case", Fertil Steril, 37, pp.851~852 (1982)
  13. Hiersch L, "Effectiveness of medical treatment with methotrexate for interstitial pregnancy", Aust N Z J Obstet Gynaecol, 54, pp.576~580 (2014)
  14. Tanaka K, "Management of interstitial ectopic pregnancy with intravenous methotrexate: an extended study of a standardised regimen", Aust N Z J Obstet Gynaecol, 55, pp.176~180 (2015)
  15. Jermy K, "The conservative management of interstitial pregnancy", BJOG, 111, pp.1283~1288 (2004)
  16. Hafner T, "The effectiveness of non-surgical management of early interstitial pregnancy: a report of ten cases and review of the literature", Ultrasound Obstet Gynecol, 13, pp.131~136 (1999)
  17. Timor-Tritsch IE, "A ‘potentially safer’ route for puncture and injection of cornual ectopic pregnancies", Ultrasound Obstet Gynecol, 7, pp.353~355 (1996)
  18. Downey GP, "Spontaneous uterine rupture during subsequent pregnancy following non-excision of an interstitial ectopic gestation", Br J Obstet Gynaecol, 101, pp.162~163 (1994)

관련 논문AI추천

Ultrasound-guided local injection of methotrexate and systemic intramuscular methotrexate in the treatment of cesarean scar pregnancy김영란, 문명진대한산부인과학회 · Obstetrics & Gynecology Science2018 · 제61권 제1호자궁경관 임신 및 제왕절개 반흔부 임신에서의 methotrexate 치료 효과 및 예후 예측 인자김종인, 박준철, 이정호대한산부인과학회 · Obstetrics & Gynecology Science2006 · 제49권 제5호약물치료의 예후가 불량한 나팔관임신에서의 초음파 유도하 임신낭내 methotrexate 주입법을 이용한 보존적 치료 2예김슬아, 신종철, 이수정, 최세경, 최정인, 황선정대한산부인과학회 · Obstetrics & Gynecology Science2012 · 제55권 제11호Pretreatment serum human chorionic gonadotropin cutoff value for medical treatment success with single-dose and multi-dose regimen of methotrexate in tubal ectopic pregnancy김준환, 이다용, 정영미, 지병철대한산부인과학회 · Obstetrics & Gynecology Science2017 · 제60권 제1호제왕절개 수술 반흔 부위에 착상한자궁벽내 임신의 Methotrexate 치료 1예김재원, 김철환, 박용균, 서호석, 이경주, 정유아, 조수용, 허준용, 홍진화, 황종하대한산부인과학회 · Obstetrics & Gynecology Science2002 · 제45권 제9호Concomitant ultrasound-guided intra-gestational sac methotrexate-potassium chloride and systemic methotrexate injection in the recurrent cesarean scar pregnancy김탁, 권대휘, 안기훈, 이주학, 홍순철대한산부인과학회 · Obstetrics & Gynecology Science2016 · 제59권 제3호

이 간행물의 다른 논문 (5건)